195 related articles for article (PubMed ID: 32210480)
1. TLR4 abrogates the Th1 immune response through IRF1 and IFN-β to prevent immunopathology during L. infantum infection.
Sacramento LA; Benevides L; Maruyama SR; Tavares L; Fukutani KF; Francozo M; Sparwasser T; Cunha FQ; Almeida RP; da Silva JS; Carregaro V
PLoS Pathog; 2020 Mar; 16(3):e1008435. PubMed ID: 32210480
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection.
Sacramento L; Trevelin SC; Nascimento MS; Lima-Jùnior DS; Costa DL; Almeida RP; Cunha FQ; Silva JS; Carregaro V
Infect Immun; 2015 Dec; 83(12):4604-16. PubMed ID: 26371124
[TBL] [Abstract][Full Text] [Related]
3. Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.
Gomes RS; Silva MVT; Dos Santos JC; van Linge C; Reis JM; Teixeira MM; Pinto SA; Dorta ML; Bai X; Chan ED; Dinarello CA; Oliveira MAP; Joosten LAB; Ribeiro-Dias F
Infect Immun; 2018 May; 86(5):. PubMed ID: 29483288
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-27 (IL-27) Mediates Susceptibility to Visceral Leishmaniasis by Suppressing the IL-17-Neutrophil Response.
Quirino GFS; Nascimento MSL; Davoli-Ferreira M; Sacramento LA; Lima MHF; Almeida RP; Carregaro V; Silva JS
Infect Immun; 2016 Aug; 84(8):2289-2298. PubMed ID: 27245409
[TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptor- and Protein Kinase R-Induced Type I Interferon Sustains Infection of
Dias BT; Goundry A; Vivarini AC; Costa TFR; Mottram JC; Lopes UG; Lima APCA
Front Immunol; 2022; 13():801182. PubMed ID: 35154115
[No Abstract] [Full Text] [Related]
6. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis.
de Jesus Pereira NC; Régis WC; Costa LE; de Oliveira JS; da Silva AG; Martins VT; Duarte MC; de Souza JR; Lage PS; Schneider MS; Melo MN; Soto M; Soares SA; Tavares CA; Chávez-Fumagalli MA; Coelho EA
Exp Parasitol; 2015 Jun; 153():180-90. PubMed ID: 25845753
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity of
Fernández L; Carrillo E; Sánchez-Sampedro L; Sánchez C; Ibarra-Meneses AV; Jimenez MA; Almeida VDA; Esteban M; Moreno J
Front Immunol; 2018; 9():843. PubMed ID: 29740446
[No Abstract] [Full Text] [Related]
9. Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
Ribeiro PAF; Dias DS; Lage DP; Costa LE; Martins VT; Tavares GSV; Mendonça DVC; Lima MP; Oliveira JS; Steiner BT; Machado-de-Ávila RA; Roatt BM; Chávez-Fumagalli MA; Menezes-Souza D; Duarte MC; Teixeira AL; Coelho EAF
Cell Immunol; 2018 Sep; 331():67-77. PubMed ID: 29871740
[TBL] [Abstract][Full Text] [Related]
10. Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis.
Dias DS; Ribeiro PAF; Martins VT; Lage DP; Portela ÁSB; Costa LE; Salles BCS; Lima MP; Ramos FF; Santos TTO; Caligiorne RB; Chávez-Fumagalli MA; Silveira JAG; Magalhães-Soares DF; Gonçalves DU; Oliveira JS; Roatt BM; Duarte MC; Menezes-Souza D; Silva ES; Galdino AS; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
Mol Immunol; 2017 Nov; 91():272-281. PubMed ID: 28988041
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection.
Nascimento MS; Carregaro V; Lima-Júnior DS; Costa DL; Ryffel B; Duthie MS; de Jesus A; de Almeida RP; da Silva JS
J Infect Dis; 2015 Mar; 211(6):1015-26. PubMed ID: 25274569
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a CD4
Dias DS; Ribeiro PAF; Martins VT; Lage DP; Costa LE; Chávez-Fumagalli MA; Ramos FF; Santos TTO; Ludolf F; Oliveira JS; Mendes TAO; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
Transl Res; 2018 Oct; 200():18-34. PubMed ID: 29908151
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.
Yen JH; Kong W; Hooper KM; Emig F; Rahbari KM; Kuo PC; Scofield BA; Ganea D
J Leukoc Biol; 2015 Nov; 98(5):689-702. PubMed ID: 26059829
[TBL] [Abstract][Full Text] [Related]
14. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
Schaut RG; Grinnage-Pulley TL; Esch KJ; Toepp AJ; Duthie MS; Howard RF; Reed SG; Petersen CA
Vaccine; 2016 Oct; 34(44):5225-5234. PubMed ID: 27665354
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
[TBL] [Abstract][Full Text] [Related]
16. Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.
Dias DS; Ribeiro PAF; Martins VT; Lage DP; Ramos FF; Dias ALT; Rodrigues MR; Portela ÁSB; Costa LE; Caligiorne RB; Steiner BT; Chávez-Fumagalli MA; Salles BCS; Santos TTO; Silveira JAG; Magalhães-Soares DF; Roatt BM; Machado-de-Ávila RA; Duarte MC; Menezes-Souza D; Silva ES; Galdino AS; Coelho EAF
Cell Immunol; 2018 Jan; 323():59-69. PubMed ID: 29128045
[TBL] [Abstract][Full Text] [Related]
17. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.
Melby PC; Chandrasekar B; Zhao W; Coe JE
J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239
[TBL] [Abstract][Full Text] [Related]
18. TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis.
Karmakar S; Bhaumik SK; Paul J; De T
PLoS Pathog; 2012; 8(4):e1002646. PubMed ID: 22511870
[TBL] [Abstract][Full Text] [Related]
19. NOD2-RIP2-Mediated Signaling Helps Shape Adaptive Immunity in Visceral Leishmaniasis.
Nascimento MS; Ferreira MD; Quirino GF; Maruyama SR; Krishnaswamy JK; Liu D; Berlink J; Fonseca DM; Zamboni DS; Carregaro V; Almeida RP; Cunha TM; Eisenbarth SS; Silva JS
J Infect Dis; 2016 Dec; 214(11):1647-1657. PubMed ID: 27651416
[TBL] [Abstract][Full Text] [Related]
20.
Kim WS; Jung ID; Kim JS; Kim HM; Kwon KW; Park YM; Shin SJ
Front Cell Infect Microbiol; 2018; 8():95. PubMed ID: 29637049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
